References
1. Mohseni Afshar Z, Babazadeh A, Hasanpour A, Barary M, Sayad B, Janbakhsh A, et al. Dermatological manifestations associated with COVID-19: A comprehensive review of the current knowledge. J Med Virol. 2021;93(10):5756-67. doi: 10.1002/jmv.27187.
2. Mohseni Afshar Z, Babazadeh A, Alizadeh Khatir A, Mohammadnia-Afrouzi M, Javanian M, Vasigala VR, et al. Neurological manifestations in COVID-19: an overview. Minerva Respiratory Medicine. 2021;60(2):52-8. doi: 10.23736/s2784-8477.20.01895-7.
3. Afshar ZM, Babazadeh A, Javanian M, Ramezani E, Shemshadi R, Ebrahimpour S. A review of cardiac involvement in COVID-19 infection. Cor et Vasa. 2020;62(6):610-5.
4. Mohseni Afshar Z, Babazadeh A, Janbakhsh A, Afsharian M, Saleki K, Barary M, et al. Vaccine-induced immune thrombotic thrombocytopenia after vaccination against Covid-19: A clinical dilemma for clinicians and patients. Rev Med Virol. 2022;32(2):e2273. doi: 10.1002/rmv.2273.
5. Mohseni Afshar Z, Sharma A, Babazadeh A, Alizadeh-Khatir A, Sio TT, Taghizadeh Moghadam MA, et al. A review of the potential neurological adverse events of COVID-19 vaccines. Acta Neurol Belg. 2023;123(1):9-44. doi: 10.1007/s13760-022-02137-2.
6. Afshar ZM, Barary M, Babazadeh A, Hosseinzadeh R, Alijanpour A, Miri SR, et al. SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review. Rev Med Virol. 2022;32(4):e2327. doi: 10.1002/rmv.2327.
7. Mohseni Afshar Z, Tavakoli Pirzaman A, Liang JJ, Sharma A, Pirzadeh M, Babazadeh A, et al. Do we miss rare adverse events induced by COVID-19 vaccination? Front Med (Lausanne). 2022;9:933914. doi: 10.3389/fmed.2022.933914.
8. Garland EM, Raj SR, Black BK, Harris PA, Robertson D. The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome. Neurology. 2007;69(8):790-8. doi: 10.1212/01.wnl.0000267663.05398.40.
9. Goldstein DS, Holmes C, Frank SM, Dendi R, Cannon RO, 3rd, Sharabi Y, et al. Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes. Circulation. 2002;106(18):2358-65. doi: 10.1161/01.cir.0000036015.54619.b6.
10. Jardine DL, Wieling W, Brignole M, Lenders JWM, Sutton R, Stewart J. The pathophysiology of the vasovagal response. Heart Rhythm. 2018;15(6):921-9. doi: 10.1016/j.hrthm.2017.12.013.
11. Low PA, Sandroni P. Chapter 106 - Postural Tachycardia Syndrome (POTS). In: Robertson D, Biaggioni I, Burnstock G, Low PA, Paton JFR, editors. Primer on the Autonomic Nervous System (Third Edition). San Diego: Academic Press; 2012. p. 517-9.
12. Raj SR. Postural tachycardia syndrome (POTS). Circulation. 2013;127(23):2336-42. doi: 10.1161/CIRCULATIONAHA.112.144501.
13. Peggs KJ, Nguyen H, Enayat D, Keller NR, Al-Hendy A, Raj SR. Gynecologic disorders and menstrual cycle lightheadedness in postural tachycardia syndrome. Int J Gynaecol Obstet. 2012;118(3):242-6. doi: 10.1016/j.ijgo.2012.04.014.
14. Morgan K, Chojenta C, Tavener M, Smith A, Loxton D. Postural Orthostatic Tachycardia Syndrome during pregnancy: A systematic review of the literature. Auton Neurosci. 2018;215:106-18. doi: 10.1016/j.autneu.2018.05.003.
15. Arnold AC, Ng J, Raj SR. Postural tachycardia syndrome - Diagnosis, physiology, and prognosis. Auton Neurosci. 2018;215:3-11. doi: 10.1016/j.autneu.2018.02.005.
16. Fedorowski A. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management. J Intern Med. 2019;285(4):352-66. doi: 10.1111/joim.12852.
17. Vance H, Maslach A, Stoneman E, Harmes K, Ransom A, Seagly K, et al. Addressing Post-COVID Symptoms: A Guide for Primary Care Physicians. J Am Board Fam Med. 2021;34(6):1229-42. doi: 10.3122/jabfm.2021.06.210254.
18. Kavi L. Postural tachycardia syndrome and long COVID: an update. Br J Gen Pract. 2022;72(714):8-9. doi: 10.3399/bjgp22X718037.
19. Miglis MG, Prieto T, Shaik R, Muppidi S, Sinn DI, Jaradeh S. A case report of postural tachycardia syndrome after COVID-19. Clin Auton Res. 2020;30(5):449-51. doi: 10.1007/s10286-020-00727-9.
20.O’Sullivan JS, Lyne A, Vaughan CJ. COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine. BMJ Case Rep. 2021;14(6):e243585. doi: 10.1136/bcr-2021-243585.
21. Johnson JN, Mack KJ, Kuntz NL, Brands CK, Porter CJ, Fischer PR. Postural orthostatic tachycardia syndrome: a clinical review. Pediatr Neurol. 2010;42(2):77-85. doi: 10.1016/j.pediatrneurol.2009.07.002.
22. Fu Q, Levine BD. Exercise and non-pharmacological treatment of POTS. Auton Neurosci. 2018;215:20-7. doi: 10.1016/j.autneu.2018.07.001.
23. Schmidt LL, Karabin BL, Malone AC. Postural Orthostatic Tachycardia Syndrome (POTS): Assess, Diagnose, and Evaluate for POTS Treatment (ADEPT). Integr Med Int. 2017;4:142-53. doi: 10.1159/000484205.
24. Junghans-Rutelonis AN, Craner JR, Ale CM, Harbeck-Weber C, Fischer PR, Weiss KE. Youth with Chronic Pain and Postural Orthostatic Tachycardia Syndrome (POTS): Treatment Mediators of Improvement in Functional Disability. J Clin Psychol Med Settings. 2018;25(4):471-84. doi: 10.1007/s10880-018-9558-7.
25. Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: An overview. Diabetes Metab Syndr. 2021;15(3):869-75. doi: 10.1016/j.dsx.2021.04.007.
26. Anand H, Ende V, Singh G, Qureshi I, Duong TQ, Mehler MF. Nervous System-Systemic Crosstalk in SARS-CoV-2/COVID-19: A Unique Dyshomeostasis Syndrome. Front Neurosci. 2021;15:727060. doi: 10.3389/fnins.2021.727060.
27. Yang J, Petitjean SJL, Koehler M, Zhang Q, Dumitru AC, Chen W, et al. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Nat Commun. 2020;11(1):4541. doi: 10.1038/s41467-020-18319-6.
28. Gunning WT, 3rd, Kvale H, Kramer PM, Karabin BL, Grubb BP. Postural Orthostatic Tachycardia Syndrome Is Associated With Elevated G-Protein Coupled Receptor Autoantibodies. J Am Heart Assoc. 2019;8(18):e013602. doi: 10.1161/JAHA.119.013602.
29. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-15. doi: 10.1038/s41591-021-01283-z.
30. Blitshteyn S, Whitelaw S. Correction to: Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res. 2021;69(2):212. doi: 10.1007/s12026-021-09191-7.
31. Novak P. Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: a case report. eNeurologicalSci. 2020;21:100276. doi: 10.1016/j.ensci.2020.100276.
32. Lamotte G, Benarroch EE, Coon EA. Paroxysmal hypothermia and hyperhidrosis with exacerbation after COVID-19 Infection. Clin Auton Res. 2021;31(2):327-9. doi: 10.1007/s10286-021-00783-9.
33. Carod-Artal FJ. Infectious diseases causing autonomic dysfunction. Clin Auton Res. 2018;28(1):67-81. doi: 10.1007/s10286-017-0452-4.
34. Kanjwal K, Karabin B, Kanjwal Y, Grubb BP. Postural orthostatic tachycardia syndrome following Lyme disease. Cardiol J. 2011;18(1):63-6.
35. Kasmani R, Elkambergy H, Okoli K. Postural Orthostatic Tachycardia Syndrome Associated With Mycoplasma pneumoniae. Infectious Diseases in Clinical Practice. 2009;17(5):342-3. doi: 10.1097/IPC.0b013e318191781b.
36. Pohlgeers KM, Stumbo JR. Syncope in an Athlete: a Case of Infectious Mononucleosis-Induced Postural Tachycardia Syndrome. Curr Sports Med Rep. 2016;15(1):41-5. doi: 10.1249/JSR.0000000000000227.
37. Ishibashi Y, Yoneyama K, Tsuchida T, Y JA. Post-COVID-19 Postural Orthostatic Tachycardia Syndrome. Intern Med. 2021;60(14):2345. doi: 10.2169/internalmedicine.7626-21.
38. Ormiston CK, Świątkiewicz I, Taub PR. Postural orthostatic tachycardia syndrome as a sequela of COVID-19. Heart rhythm. 2022;19(11):1880-9.
39. Ladlow P, O’Sullivan O, Houston A, Barker-Davies R, May S, Mills D, et al. Dysautonomia following COVID-19 is not associated with subjective limitations or symptoms but is associated with objective functional limitations. Heart Rhythm. 2022;19(4):613-20.
40. Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, Lifelines Corona Research I. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400(10350):452-61. doi: 10.1016/S0140-6736(22)01214-4.
41. Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, Condition WHOCCDWGoP-C-. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102-e7. doi: 10.1016/S1473-3099(21)00703-9.
42. Raj SR, Guzman JC, Harvey P, Richer L, Schondorf R, Seifer C, et al. Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance. Can J Cardiol. 2020;36(3):357-72. doi: 10.1016/j.cjca.2019.12.024.
43. Grubb BP. Autonomic Dysfunction as a Consequence of COVID-19 Infection: A New Twist on an Old Problem. J Am Coll Cardiol. 2022;79(23):2331-2. doi: 10.1016/j.jacc.2022.04.007.
44. Blitshteyn S, Fedorowski A. The risks of POTS after COVID-19 vaccination and SARS-CoV-2 infection: it’s worth a shot. Nat Cardiovasc Res. 2022;1(12):1119-20. doi: 10.1038/s44161-022-00180-z.
45. Kwan AC, Ebinger JE, Wei J, Le CN, Oft JR, Zabner R, et al. Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 Infection. Nat Cardiovasc Res. 2022;1(12):1187-94. doi: 10.1038/s44161-022-00177-8.
46. Shiravi AA, Ardekani A, Sheikhbahaei E, Heshmat-Ghahdarijani K. Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview. Cardiol Ther. 2022;11(1):13-21. doi: 10.1007/s40119-021-00248-0.
47. Brinth LS, Pors K, Theibel AC, Mehlsen J. Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus. Vaccine. 2015;33(22):2602-5. doi: 10.1016/j.vaccine.2015.03.098.
48. Skufca J, Ollgren J, Ruokokoski E, Lyytikainen O, Nohynek H. Incidence rates of Guillain Barre (GBS), chronic fatigue/systemic exertion intolerance disease (CFS/SEID) and postural orthostatic tachycardia syndrome (POTS) prior to introduction of human papilloma virus (HPV) vaccination among adolescent girls in Finland, 2002-2012. Papillomavirus Res. 2017;3:91-6. doi: 10.1016/j.pvr.2017.03.001.
49. Blitshteyn S. Postural tachycardia syndrome after vaccination with Gardasil. Eur J Neurol. 2010;17(7):e52. doi: 10.1111/j.1468-1331.2010.03021.x.
50. Hermel M, Sweeney M, Abud E, Luskin K, Criado JP, Bonakdar R, et al. COVID-19 Vaccination Might Induce Postural Orthostatic Tachycardia Syndrome: A Case Report. Vaccines (Basel). 2022;10(7):991. doi: 10.3390/vaccines10070991.
51. Anaya J-M, Herrán M, Beltrán S, Rojas M. Is post-COVID syndrome an autoimmune disease? Expert Review of Clinical Immunology. 2022;18(7):653-66.
52. Phu T, Tran TT, Hao HT, Hau NTH, Jain N. Postural Orthostatic Tachycardia Syndrome (POTS) Following COVID-19 Vaccination. 2022. doi: 10.13140/RG.2.2.14787.07200.
53. Karimi Galougahi K. Autonomic dysfunction post-inoculation with ChAdOx1 nCoV-19 vaccine. Eur Heart J Case Rep. 2021;5(12):ytab472. doi: 10.1093/ehjcr/ytab472.
54. Finsterer J. Small fiber neuropathy underlying dysautonomia in COVID-19 and in post-SARS-CoV-2 vaccination and long-COVID syndromes. Muscle Nerve. 2022;65(6):E31-E2. doi: 10.1002/mus.27554.
55. Eldokla AM, Numan MT. Postural orthostatic tachycardia syndrome after mRNA COVID-19 vaccine. Clin Auton Res. 2022;32(4):307-11. doi: 10.1007/s10286-022-00880-3.
56. Reddy S, Reddy S, Arora M. A Case of Postural Orthostatic Tachycardia Syndrome Secondary to the Messenger RNA COVID-19 Vaccine. Cureus. 2021;13(5):e14837. doi: 10.7759/cureus.14837.
57. Maharaj N, Swarath S, Seecheran R, Seecheran V, Panday A, Seecheran N. Suspected COVID-19 mRNA Vaccine-Induced Postural Orthostatic Tachycardia Syndrome. Cureus. 2023;15(1):e34236. doi: 10.7759/cureus.34236.
58. Park J, Kim S, Lee J, An JY. A case of transient POTS following COVID-19 vaccine. Acta Neurol Belg. 2022;122(4):1081-3. doi: 10.1007/s13760-022-02002-2.